Macro Dragon: Equities Divergence, Technical Check in on the divergence on AirBnB [ABNB], Compass Pathways [CMPS] & Beyond Meat [BYND]

Macro Dragon: Equities Divergence, Technical Check in on the divergence on AirBnB [ABNB], Compass Pathways [CMPS] & Beyond Meat [BYND]

Macro 4 minutes to read
Kay Van-Petersen

Global Macro Strategist

Summary:  Macro Dragon = Cross-Asset Quasi-Daily Views that could cover anything from tactical positioning, to long-term thematic investments, key events & inflection points in the markets, all with the objective of consistent wealth creation overtime.


(These are solely the views & opinions of KVP, & do not constitute any trade or investment recommendations. By the time you synthesize this, things may have changed.)

Macro Dragon: Technical Check-in on the Equities Divergences on AirBnB [ABNB], Compass Pathways [CMPS] & Beyond Meat [BYND]


Top of Mind…

  • As KVP gets back in the game, its been flagged by our world class Global Sales Trading Team - that we need more equity focus pieces for our clients... so we are just gonna check into three names that we've covered on the Macro Dragon before

  • As always, be wary of any equity analyst talking about equites, let alone the Macro Dude talking about equities... :)

  • Let’s start with the underperformer, BYND – which the Dragon has been covering for a whilst, since it actually listed. The Macro Skew on this was covered in Aug 2020; Erns Watch: Beyond Meat, Alternative Protein Theme & Macro Sins -  which touched on the Alternative Protein Space from a Meta Perspective.

  • KVP still has to catch-up with the latest fundamentals – previous quarter saw them continuing to invest in R&D & rebooting their European strategy, shifting from a partnership to driving it themselves. Next scheduled earnings date is after market on the Nov 10th

  • The chart & stock price has been ugly for the bulls & a delight for the bears – the 1Q spike was the GameStop/WSB/SME squeeze, followed by a similar smaller wave in the end of 2Q.

    BYND - 6m chart

  • Low for the year is $91.55 lvls, with key resistance likely being in the $120-130 range, from these $102 lvls. Its worth noting the short-interest as a % of the float is c. 28%, with c. 8x to cover as of 14 days ago. So we could see some shorts being covered as we approach the earnings date & a squeeze if there is an upbeat surprise. BYND has had 4 consecutive negative months where it has dropped from 157.49 to 98.98 for the close of Oct, that’s a -37% fall.

  • On the other hand, in just 1m alone Compass Pathways [CMPS] is up over +55%, in an example of where patience has paid off. We’ve touched on CMPS since its listing last year; Macro Dragon: Putting Compass on the Map... Mycelium, Magic Mushrooms + Psychedelics for Medicine & Treatment - with the key catalyst always being 2H21 on the results of the clinical trials.

    CMPS - 6m chart

  • The chart is breaking out big time past $40 previous resistance lvl. At $46.66, the next likely key lvls to test will be $50 & the all time high of c. $62. This is not a chart that KVP would be short, unless there was a specific event-driven catalyst as a play. Its worth noting that CMPS is set to report on Nov 12.

  • Lastly with at least no near-term earnings risk, we had AirBnB[ABNB] reporting yesterday, whilst it close dup +3.2% at 178.45, the results were post market & its currently looking indicated at 184.60/185.00, a c. +3-4% uplift on yest.’s close.

ABNB - 6m chart
 

  • The likely next key lvl to test on ABNB is $200, with support being offering at the $160 lvl. It will be interesting to see how it trades on this NFP Friday. Good wkd folks.

-

Start<>End = Gratitude + Integrity + Vision + Tenacity | Process > Outcome | Sizing > Position.

This is The Way

Namaste,
KVP

Quarterly Outlook

01 /

  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

  • FX outlook: Tariffs drive USD strength, until...?

    Quarterly Outlook

    FX outlook: Tariffs drive USD strength, until...?

    John J. Hardy

    Global Head of Macro Strategy

  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992